• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及平均血小板体积与淋巴细胞比值对老年心力衰竭患者近期主要心血管不良事件的预测价值

Predictive value of NLR, PLR and MPVLR for recent major cardiovascular adverse events in elderly patients with heart failure.

作者信息

Ren Zijuan, Xu Fei, Wei Zheng

机构信息

Department of Cardiology, Suzhou Municipal Hospital of Anhui Province Suzhou 234000, Anhui, China.

出版信息

Am J Transl Res. 2025 Jul 15;17(7):4964-4975. doi: 10.62347/XQNT2355. eCollection 2025.

DOI:10.62347/XQNT2355
PMID:40821098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12351568/
Abstract

OBJECTIVE

To evaluate the application value of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and mean platelet volume to lymphocyte ratio (MPVLR) levels in identifying recent major cardiovascular adverse events (MACE) in elderly patients with heart failure (HF).

METHOD

A total of 103 elderly HF patients admitted to Suzhou Hospital affiliated to Anhui Medical University from January 2022 to February 2025 were selected as the model group, and 74 patients from the same period served as the external validation group. All patients were followed up for 3 months after treatment. Patients were categorized into a MACE group and a non-MACE group based on the occurrence of MACE. Clinical data and levels of NLR, PLR, and MPVLR, were compared between the two groups. Multivariate logistic regression analysis was conducted to identify the independent risk factors for recent MACE. A forest plot was drawn using Graphpad Prism 8.0 software. Predictive models were evaluated using receiver operating characteristic (ROC) curves and calibration curves.

RESULTS

Patients in the MACE group were older and had a higher prevalence of diabetes compared to the non-MACE group. Levels of NLR, PLR, and MPVLR were significantly elevated in the MACE group. Multivariate logistic regression analysis identified NLR ( = 7.928, 2.633-23.869), PLR ( = 1.077, 1.038-1.117), MPVLR ( = 1.688, 1.134-2.513) as risk factors for recent MACE in elderly HF patients (all < 0.05). ROC curve analysis showed that the combined use of NLR, PLR, and MPVLR had superior predictive performance compared to individual indicators ( < 0.05). The predictive model demonstrated superior discriminative ability compared to individual indicators (AUC = 0.919), which was further validated in the external validation group (AUC = 0.810), indicating consistent predictive accuracy.

CONCLUSION

Elevated levels of NLR, PLR, and MPVLR can serve as independent risk factors for assessing the risk of recent MACE in elderly HF patients. The combined predictive model demonstrates high accuracy and may assist in early risk stratification and personalized preventive strategies to reduce the risk of MACE.

摘要

目的

评估中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及平均血小板体积与淋巴细胞比值(MPVLR)水平在识别老年心力衰竭(HF)患者近期主要心血管不良事件(MACE)中的应用价值。

方法

选取2022年1月至2025年2月在安徽医科大学附属苏州医院收治的103例老年HF患者作为模型组,同期74例患者作为外部验证组。所有患者治疗后随访3个月。根据MACE的发生情况将患者分为MACE组和非MACE组。比较两组的临床资料以及NLR、PLR和MPVLR水平。进行多因素logistic回归分析以确定近期MACE的独立危险因素。使用Graphpad Prism 8.0软件绘制森林图。采用受试者工作特征(ROC)曲线和校准曲线评估预测模型。

结果

与非MACE组相比MACE组患者年龄更大且糖尿病患病率更高。MACE组的NLR、PLR和MPVLR水平显著升高。多因素logistic回归分析确定NLR( =7.928, 2.633 - 23.869)、PLR( =1.077, 1.038 - 1.117)、MPVLR( =1.688, 1.134 - 2.513)为老年HF患者近期MACE的危险因素(均 <0.05) ROC曲线分析显示与单个指标相比NLR、PLR和MPVLR联合使用具有更好的预测性能( <0.05)。预测模型显示出比单个指标更好的判别能力(AUC =0.919)在外部验证组中得到进一步验证(AUC =0.810)表明预测准确性一致。

结论

NLR、PLR和MPVLR水平升高可作为评估老年HF患者近期MACE风险的独立危险因素。联合预测模型显示出较高的准确性可能有助于早期风险分层和个性化预防策略以降低MACE风险。

相似文献

1
Predictive value of NLR, PLR and MPVLR for recent major cardiovascular adverse events in elderly patients with heart failure.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及平均血小板体积与淋巴细胞比值对老年心力衰竭患者近期主要心血管不良事件的预测价值
Am J Transl Res. 2025 Jul 15;17(7):4964-4975. doi: 10.62347/XQNT2355. eCollection 2025.
2
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
3
Association of platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and monocyte-lymphocyte ratio with coronary heart disease prevalence in asthma patients: a cross-sectional analysis of NHANES 1999-2018.血小板-淋巴细胞比值、中性粒细胞-淋巴细胞比值和单核细胞-淋巴细胞比值与哮喘患者冠心病患病率的关联:1999 - 2018年美国国家健康与营养检查调查的横断面分析
J Thorac Dis. 2025 Jun 30;17(6):3831-3839. doi: 10.21037/jtd-24-1761. Epub 2025 Jun 13.
4
Relationship between lymphocyte-related parameters and the prognosis of patients with lupus nephritis.淋巴细胞相关参数与狼疮性肾炎患者预后的关系。
Front Immunol. 2025 Jul 8;16:1613483. doi: 10.3389/fimmu.2025.1613483. eCollection 2025.
5
Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).血小板与淋巴细胞比值(PLR)、中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)和嗜酸性粒细胞与淋巴细胞比值(ELR)作为慢性阻塞性肺疾病急性加重(AECOPD)患者的生物标志物。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 23;19:501-518. doi: 10.2147/COPD.S447519. eCollection 2024.
6
Application value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting stress ulcer after acute cerebral hemorrhage surgery.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值在预测急性脑出血手术后应激性溃疡中的应用价值。
Clin Neurol Neurosurg. 2024 Nov;246:108557. doi: 10.1016/j.clineuro.2024.108557. Epub 2024 Sep 16.
7
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及单核细胞与淋巴细胞比值(MLR)作为慢性阻塞性肺疾病急性加重诊断评估的生物标志物:一项回顾性观察研究
Int J Chron Obstruct Pulmon Dis. 2024 Apr 15;19:933-943. doi: 10.2147/COPD.S452444. eCollection 2024.
8
The Prognostic Potential of Insulin-like Growth Factor-Binding Protein 1 for Cardiovascular Complications in Peripheral Artery Disease.胰岛素样生长因子结合蛋白1对周围动脉疾病心血管并发症的预后评估价值
J Cardiovasc Dev Dis. 2025 Jul 1;12(7):253. doi: 10.3390/jcdd12070253.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
The correlation between lipoprotein(a) and major adverse cardiovascular events in patients with acute myocardial infarction combined with heart failure with preserved ejection fraction.急性心肌梗死合并射血分数保留的心力衰竭患者中脂蛋白(a)与主要不良心血管事件的相关性。
Front Cardiovasc Med. 2025 Jun 9;12:1515916. doi: 10.3389/fcvm.2025.1515916. eCollection 2025.

本文引用的文献

1
Myocardial contrast echocardiography evaluation of coronary microvascular dysfunction to Predict MACEs in patients with heart failure with preserved ejection fraction follow-up.心肌声学造影评估冠状动脉微血管功能障碍预测射血分数保留的心力衰竭患者的主要不良心血管事件的随访。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):496. doi: 10.1186/s12872-024-04173-7.
2
Association between blood inflammatory indices and heart failure: a cross-sectional study of NHANES 2009-2018.血液炎症指标与心力衰竭之间的关联:一项针对2009 - 2018年美国国家健康与营养检查调查(NHANES)的横断面研究。
Acta Cardiol. 2024 Jun;79(4):473-485. doi: 10.1080/00015385.2024.2356325. Epub 2024 May 21.
3
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.钠-葡萄糖共转运蛋白 2 抑制剂与主要不良心血管结局:SMART-C 协作荟萃分析。
Circulation. 2024 Jun 4;149(23):1789-1801. doi: 10.1161/CIRCULATIONAHA.124.069568. Epub 2024 Apr 7.
4
Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab.平均血小板体积与淋巴细胞比值:一种预测接受纳武单抗治疗的实体瘤患者反应的新生物标志物。
J Immunother Precis Oncol. 2023 Dec 2;6(4):170-176. doi: 10.36401/JIPO-23-3. eCollection 2023 Nov.
5
Temporal trends, sex differences, and age-related disease influence in Neutrophil, Lymphocyte count and Neutrophil to Lymphocyte-ratio: results from InCHIANTI follow-up study.中性粒细胞、淋巴细胞计数及中性粒细胞与淋巴细胞比值的时间趋势、性别差异和年龄相关疾病影响:基安蒂研究随访结果
Immun Ageing. 2023 Sep 4;20(1):46. doi: 10.1186/s12979-023-00370-8.
6
The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study.抗高血压治疗与年龄和虚弱相关的严重不良事件的关联:一项队列研究。
PLoS Med. 2023 Apr 19;20(4):e1004223. doi: 10.1371/journal.pmed.1004223. eCollection 2023 Apr.
7
Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study.血小板与淋巴细胞比值在急性心肌梗死中的预后预测价值:一项前瞻性纵向研究。
Clin Cardiol. 2023 Jun;46(6):632-638. doi: 10.1002/clc.24002. Epub 2023 Apr 14.
8
Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 Trial.心脏生物标志物与糖尿病高危患者主要不良心血管事件的关系:DECLARE-TIMI 58 试验的二次分析。
JAMA Cardiol. 2023 May 1;8(5):503-509. doi: 10.1001/jamacardio.2023.0019.
9
The role of platelets in immune-mediated inflammatory diseases.血小板在免疫介导的炎症性疾病中的作用。
Nat Rev Immunol. 2023 Aug;23(8):495-510. doi: 10.1038/s41577-023-00834-4. Epub 2023 Jan 27.
10
Association of GNRI, NLR, and FT3 with the Clinical Prognosis of Older Patients with Heart Failure.老年心力衰竭患者的肾小球滤过率与营养风险指数、中性粒细胞与淋巴细胞比值及游离三碘甲状腺原氨酸与临床预后的相关性
Int Heart J. 2022;63(6):1048-1054. doi: 10.1536/ihj.22-306.